Back to funds

MPM BioImpact LLC

Updated 6 days ago

Managed by Mpm Bioimpact Llc • Latest filing Q3 2026

Portfolio value
$1.3B
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
96.4%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$874M
Q1 2026$1.3B
Q2 2026$1.6B
Q3 2026$1.3B

Top holdings

37 positions as of Q3 2026

View filing
C

Cullinan Therapeutics, Inc.

Value
$149.2M
Shares
9.72M
% Port
11.07%
A

Aktis Oncology, Inc.

Value
$94.2M
Shares
4.84M
% Port
6.99%
T

Travere Therapeutics Inc

Value
$64.1M
Shares
1.09M
% Port
4.75%
E

Edgewise Therapeutics Inc

Value
$64M
Shares
1.58M
% Port
4.75%
D

Dyne Therapeutics, Inc.

Value
$51.7M
Shares
3.21M
% Port
3.83%
C

Corcept Therapeutics, Inc.

Value
$48.6M
Shares
422.0K
% Port
3.61%
C

Corcept Therapeutics, Inc.

Value
$48.6M
Shares
422.0K
% Port
3.61%
R

Relay Therapeutics Inc.

Value
$42.8M
Shares
2.37M
% Port
3.17%
T

Trevi Therapeutics Inc

Value
$42.7M
Shares
2.98M
% Port
3.17%
J

Iovance Biotherapeutics, Inc.

Value
$42M
Shares
2.84M
% Port
3.12%
L

Liquidia Corporation

Value
$40.6M
Shares
1.34M
% Port
3.01%
N

Natera Inc

Value
$37.4M
Shares
90.6K
% Port
2.78%
U

Urogen Pharma Ltd

Value
$37M
Shares
909.7K
% Port
2.74%
I

Immunocore Holdings plc

Value
$36.4M
Shares
1.20M
% Port
2.70%
D

DBV Technologies S A

Value
$35.8M
Shares
3.04M
% Port
2.66%
T

Taysha Gene Therapies, Inc.

Value
$35.4M
Shares
7.26M
% Port
2.62%
A

Abivax SA

Value
$32.5M
Shares
328.4K
% Port
2.41%
V

Vir Biotechnology, Inc.

Value
$31.4M
Shares
2.81M
% Port
2.33%
A

Adlai Nortye Ltd

Value
$31.3M
Shares
1.96M
% Port
2.32%
V

Verastem, Inc.

Value
$31M
Shares
3.85M
% Port
2.30%

Explore